Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
beractant (survanta) (1 trial)
thienoyridine (1 trial)
bradanicline (1 trial)
buprenorphine (1 trial)
varenicline (chantix) (1 trial)
Attention Deficit Disorder with Hyperactivity (Phase 2)
Coronary Artery Disease (Phase 4)
Opioid-Related Disorders (Phase 2)
Tobacco Use Disorder (Phase 2)
Trials (4 total)
Trial APIs (5 total)